Organization: Teralys Capital

The Short Report – May 19, 2021: Ottawa injects $200 million into domestic vaccine manufacturing capacity, CAN Health Network project extended, nuclear leaders prepare CANDU reactors for decommissioning, and more

Resilience Biotechnologies receives significant funding to produce made-in-Canada vaccines, Ottawa extends the CAN Health Network project in Ontario by one year with a $3.25-million investment, Canada’s nuclear leaders collaborate on the decommissioning process, and more.

Feds name first set of VCCI investments

The federal government is backing five large venture capital (VC) fund of funds (FoF) to boost the much-needed late-stage capital available to Canadian tech firms.

Celtic House launches media communications fund

Celtic House Venture Partners has closed a $105-million fund that will invest in promising early-stage media communications technology (MCT). This is the fourth fund launched by Celtic House, which currently manages three other funds with $425 million in assets. Fund IV is backed by the Ontario Venture Fund, Teralys Capital, Export Development Canada and BDC…

TVM Capital closes $150-million life sciences fund

TVM Capital has closed a $150-million venture fund focused on early-stage drug development and life sciences firms. Investment in TVM Life Science Ventures VII is led by Teralys Capital with $65 million. Other investors in the Montreal-based fund include Eli Lilly & Co, BDC Venture Capital, Fondaction and Advantus Capital Management, a subsidiary of the…

Quebec government invests $50 million in clean tech VC

The Quebec government has invested $50 million in the privately run Cycle Capital Management (CCM) venture capital fund aimed at clean tech, with the potential for another $25 million if the fund can secure enough matching industry funding. The fund — Cycle Capital Fund III — targets companies at the commercialization stage that are looking…